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Abstract
Objective—The objective of this study is to evaluate discriminative validity of the Young Mania 
Rating Scale (YMRS) and Children’s Depression Rating Scale – Revised (CDRS-R) in a clinical 
sample of children when administered in an unfiltered manner (i.e., regardless of whether 
symptoms occur in a mood episode).
Method—The Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS) is the gold 
standard for assessing psychiatric disorders in children and was used to make diagnoses in this 
study. Using a sample of 707 treatment-seeking youth (aged 6–12 years, Mage = 9.7 years, 67.6% 
male), receiver operating curve analyses were performed and diagnostic likelihood ratios (DLRs) 
were calculated to evaluate the ability to change the odds and differentiate bipolar disorder (BD) 
from other disorders (using the YMRS) and depression from other disorders (using the CDRS-R).
Results—Using unfiltered administration, the YMRS achieved good discriminative validity 
when classifying BD compared to other disorders (AUC = .86) and increased odds of a bipolar 
diagnosis given a score in the highest quintile (DLR = 6.12). Using unfiltered administration, the 
CDRS-R achieved moderate to good discriminative validity in classifying depressive disorders 
(DD) compared to other disorders (AUCBD in comparison = .78; AUCBD not in comparison = .84) and 
slightly increased odds of DD given a score in the highest quintile (DLRBD in comparison = 3.12; 
DLRBD not in comparison = 5.08).
Conclusions—The YMRS and CDRS-R have moderate to good discriminative validity when 
administered in an unfiltered way in a sample of treatment seeking youth.
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Pediatric bipolar disorder (BD) is associated with a host of negative outcomes, including 
substance abuse, school failure, aggression, and suicide (Lewinsohn, Klein, & Seeley, 1995; 
Findling et al., 2001; Geller et al., 2003; Lewinsohn, Seeley, & Klein, 2003). Given its early 
onset and chronicity, persons with BD are more likely than the general population to have 
illnesses such as obesity, diabetes, and heart disease (Goldstein, Liu, Schaffer, Sala, & 
Blanco, 2013), develop them earlier, and die from them sooner (World Health Organization, 
2011). In adults, the aggregate cross-study estimated lifetime prevalence of BD is about 1%, 
with a range of 0.8% to 3.3% (Merikangas & Pato, 2009). In youth, disparate rates of BD 
are reported in epidemiological studies, with hypomania ranging from 0% to 0.9% and 
mania ranging from 0.4% to 1.9% (Merikangas & Pato, 2009). A meta-analysis of published 
epidemiologic studies found the overall rate of pediatric bipolar disorder to be 1.8% (95% 
CI, 1.1%–3.0%; Van Meter, Moreira, & Youngstrom, 2011).
There has been a dramatic increase in the diagnosis of BD in youth since the mid-1990s 
(Danner et al. 2009; Moreno et al. 2007; Blader & Carlson, 2007). Rates at hospital 
discharge increased linearly from 1.3 to 7.3 per 10,000 from 1996 to 2004 (Blader & 
Carlson, 2007). In outpatient clinics, rates range from 6% to 17%; one inpatient study found 
30% of youth had manic symptoms (Youngstrom & Duax, 2005). As there is no secular 
trend in epidemiological rates for community samples (Van Meter et al., 2011), these 
increased clinical rates most likely reflect changes in awareness and clinical practice. 
Additionally, BD in youth has received increased scientific attention; the number of research 
articles increased from less than 500 between 1986–1990 to over 2000 between 2006–2010 
(Fristad & Algorta, 2013, p. 738).
As research on BD in children continues to increase, it is important to examine the most 
commonly used outcome measures. The quality, applicability, and utility of clinical trials of 
pediatric BD rely on their accurate and appropriate interpretation. The American Academy 
of Child and Adolescent Psychiatry, as part of their Best Practice efforts, recommends using 
the Young Mania Rating Scale (YMRS; Young et al., 1978) and the Children’s Depression 
Rating Scale – Revised (CDRS-R; Poznanski et al., 1984) (Carlson et al., 2003); they are the 
two most commonly used outcome measures in pediatric BD research (Youngstrom, 
Findling, Youngstrom, & Calabrese, 2005).
Both the YMRS and CDRS-R assess symptom severity. They are not intended to be 
diagnostic tools nor do they cover all diagnostic criteria. They can be administered two 
ways: “filtered” or “unfiltered”. Filtered measures refer to assessments that take into account 
whether or not symptoms occur within the context of a mood episode. They tend to be 
lengthy semi-structured interviews, taking into account onset, duration, lifetime occurrence, 
baseline functioning and changes from it, as well as symptom episodicity and chronicity. 
Current symptoms are interpreted differentially (e.g., chronic hyperactivity consistent with a 
child’s attention deficit hyperactivity disorder [ADHD] would not be counted as a symptom 
whereas episodic [or significantly exacerbated] hyperactivity that occurs in the context of 
other mood symptoms would be counted). Therefore, filtered measures incorporate 
information that would help with diagnostic formulation. Symptoms counted during filtered 
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administration of the YMRS and CDRS-R are not manifestations of other childhood 
disorders.
Unfiltered measures tend to be clinician-rated or self-report measures that are fairly quick to 
complete. They capture current symptom presentation and severity regardless of change 
from baseline functioning and without considering the context of mood episodes. They do 
not differentiate chronic from episodic symptoms, nor do they account for symptom onset or 
duration. Therefore, unfiltered measures can be quick to administer and are intended to 
capture symptom severity but may be less suited for use as diagnostic tools.
YMRS and CDRS-R administration is considered unfiltered if conducted in a “what you see 
is what you get” manner. Therefore, symptoms counted on the YMRS and CDRS-R, when 
administered in an unfiltered way, may be manifestations of other childhood disorders that 
have symptom overlap with mood disorders (see Tables 1–2).
The YMRS is an 11-item clinician-rated scale originally designed for use with inpatient 
adults, where it showed good reliability and validity. It was created to measure symptom 
severity after a manic episode had been determined. Item scores were based on the past 48 
hours and clinician observation during the interview, with an emphasis on the latter (Young 
et al, 1978), and was intended to get a snapshot of patients’ manic symptom severity. In 
youth aged 6–12, the YMRS has been found to differentiate inpatient children with BD from 
inpatient and outpatient children with ADHD (Fristad, Weller, & Weller, 1992; Fristad, 
Weller, & Weller, 1995). Frazier et al. (2007) found efficiency of the YMRS for 
discriminating BD from other disorders was excellent (AUCs = 0.92–0.99) in children aged 
4–17 who were divided into four age groups: 4–7 years, 8–10 years, 11–13 years, and 14–17 
years. These studies explicitly stated the YMRS was administered in a filtered way: “Scores 
were made by the clinician after combining impressions from the child’s and parents’ 
clinical interviews,” or the YMRS was completed by a clinician who had first administered a 
detailed interview, indicating the YMRS was administered in a filtered way (Fristad, Weller, 
Weller, 1992 p. 253; Frazier et al., 2007). Another study found the YMRS was able to 
discriminate children aged 8–17 with ADHD and mania from those with ADHD without 
mania, but the YMRS method of administration was not reported (Serrano, Ezpeleta, Alda, 
Matali, & San, 2011).
The CDRS-R is a 17-item clinician-administered and rated scale, with 14 items scored from 
verbal responses and 3 items scored from observation during the interview (Poznanski et al. 
1984). It is intended to be administered as a semi-structured interview as a filtered measure 
(Poznanski, Freeman, & Mokros, 1985). Children with depression have been found to 
receive significantly higher mean total scores than children without depression (Poznanzki et 
al., 1984).
Therefore, previous studies have demonstrated the YMRS and CDRS-R are able to 
discriminate BD and depression, respectively, from other disorders or no disorder when 
administered in a filtered way (Poznanzki et al., 1984; Fristad, Weller, & Weller, 1992; 
Fristad, Weller, & Weller, 1995; Frazier et al., 2007).
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Clinical research on pediatric BD uses the YMRS and CDRS-R as outcome measures with 
the assumption that they are measuring manic and depressive symptomatology, respectively. 
Previous studies that have used filtered administration support this claim. However, 
unfiltered administration has not been explicitly studied. Since administration method of the 
YMRS and CDRS-R is rarely reported in clinical research, it is important to examine the 
discriminative validity of these two commonly used outcome measures when administered 
in an unfiltered manner.
Unfiltered administration of the YMRS and CDRS-R may be the preferred method because 
it is faster. Additionally, unfiltered administration may be the default method in clinical or 
research settings where clinicians are not trained or instructed to clearly determine the 
presence of a mood episode before administering the YMRS and CDRS-R. In settings that 
emphasize symptom presentation, unfiltered administration may be preferred and more 
practical.
For two main reasons, we expected unfiltered administration of the YMRS and CDRS-R to 
show significantly lower discriminative validity than previous findings based on filtered 
administration (e.g., Youngstrom et al., 2005; Frazier et al., 2007). First, there is substantial 
nosological overlap between mood disorders (i.e., mania and depression) and other more 
common childhood disorders such as ADHD, disruptive behavior disorders (i.e., 
Oppositional Defiant Disorder [ODD]/Conduct Disorder [CD]), and anxiety disorders 
(Tables 1–2). Thus, the same symptom could occur due to a variety of diagnoses or 
developmental pathways. Second, pediatric BD has high rates of comorbidity. ADHD, 
disruptive behavior disorders (i.e., ODD/CD), and anxiety disorders occur along with BD at 
higher rates than expected in the general population. ADHD has been found to be comorbid 
with BD 59% – 93% of the time (Carlson & Meyer, 2006); a meta-analysis reported 67% 
(Kowatch, Youngstrom, Danielyan, & Findling, 2005). ODD/CD is comorbid with BD 43 – 
91% of the time and anxiety disorders 12 – 59% of the time (Carlson & Meyer, 2006). These 
high comorbidity rates complicate assessment of mania because “textbook” presentations of 
mania are rare and common comorbid conditions have higher base rates than BDs 
(Youngstrom, Findling, Youngstrom, & Calabrese, 2005).
There are serious methodological and clinical implications if unfiltered administration of the 
YMRS and CDRS-R has poor discriminative validity. If so, the quicker, unfiltered 
administration of the YMRS and CDRS-R would not be able to reliably differentiate manic 
and depressive symptoms from other symptomatology, invalidating statements that they 
measure specifically manic and depressive symptoms and compromising their efficacy as 
mood symptomatology outcome measures in clinical research.
The purpose of this study was to examine discriminative validity of the YMRS and CDRS-R 
when administered in an unfiltered way. Our first hypothesis was that total scores of 
unfiltered YMRS and CDRS-R would be significantly higher among cases with BD and 
depressive disorders (DD), respectively. Our second set of hypotheses was that unfiltered 
administration would result in significantly lower discriminative validity than previously 
found with filtered administration of the same instrument for the same diagnostic 
comparisons. We predicted that unfiltered administration of the YMRS and CDRS-R would 
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have significantly lower discriminative validity due to nosological overlap and comorbid 
presentations than reported in prior work using filtered ratings (e.g., Youngstrom et al., 
2005; Frazier et al., 2007).
Method
Participants
The LAMS study is a multicenter study conducted at nine outpatient clinics associated with 
four locations: Case Western Reserve University, Western Psychiatric Institute and Clinic, 
Cincinnati Children’s Hospital Medical Center, and The Ohio State University. The LAMS 
study is a prospective, longitudinal study of 621 children with elevated symptoms of mania 
(ESM+) and a comparison group of 86 children without elevated symptoms of mania (ESM
−). A thorough description of recruitment strategies, sample characteristics and 
methodologic detail can be found in prior publications (Horwitz et al., 2010; Findling et al., 
2010).
The current study analyzed baseline data from 707 LAMS children. Children’s ages ranged 
from 6 years 0 months to 12 years 11 months of age (average, 9.7 years) A majority was 
male (68%), white (64%), and receiving Medicaid (52%); a minority lived with both parents 
(32%). Approximately one-quarter (n=162, 23%) had a bipolar spectrum disorder (BPSD): 
77 had bipolar disorder NOS (BP-NOS), 71 had bipolar I disorder (BP-I), 11 had 
cyclothymic disorder, and 3 had bipolar II disorder (BP-II).
Procedures
The study was approved by institutional review boards at each university-affiliated LAMS 
site. Informed consent was obtained before screening; informed consent and assent were 
obtained before baseline, prior to any respective study procedures. Screening was conducted 
using 10 items from the 73-item Parent General Behavior Inventory (PGBI) that best 
discriminate BD from other disorders; the PGBI-10M has been found to have excellent 
reliability (Findling et al., 2002; Youngstrom et al., 2004; Youngstrom, Findling, Danielson, 
& Calabrese, 2001; Youngstrom, Frazier, Demeter, Calabrese, & Findling, 2008). All 
children with PGBI-10M scores ≥ 12 (i.e., ESM+) were invited to participate. One ESM− 
(i.e., score ≤ 11) participant similar in age (within 2 years), sex, race/ethnicity, and type of 
insurance as the “modal” ESM+ participant, was invited to enroll in the longitudinal portion 
of the study for every ten consecutive ESM+ participants enrolled. Groups did not 
significantly differ on any previously mentioned variables (Horwitz et al., 2010; Findling et 
al., 2010). Baseline assessment was conducted 3–6 weeks after screening. Participants were 
compensated $80 for a baseline assessment that could last 7–8 hours (based on a pay scale 
of $10/hour). Information gathered at baseline included: 1) demographics; 2) functional 
assessment; 3) diagnoses; and 4) symptomatic assessment.
Interviewers
Baseline assessments were conducted by interviewers, with an educational background that 
ranged from post-baccalaureate to post-doctoral, who had experience with psychiatrically 
impaired children and completed extensive training with strict inter-rater reliability 
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requirements. Interviewers were required to match seven diagnostic categories on the K-
SADS-PL-W, and obtain satisfactory item-level weighted kappas (κ ≥ .40) for the CDRS-R, 
YMRS, and KSADS-PL-W. Item-level kappas are partly dependent on the size of the item 
pool, similar to Cronbach’s alpha, so the same threshold is harder to achieve with shorter 
scales; however, values >.40 are considered adequate in all conventional benchmarking 
schemes. Raters achieved a κ of 0.82 for all KSADS-PL-W psychiatric diagnoses, 0.93 for 
bipolar diagnoses, 0.47 for the CDRS-R, and 0.41 for the YMRS. Note that kappas at the 
item level are different in structure, calculation, and typical benchmarks than kappas at the 
diagnosis level (Siegel & Castellan, 1988). The same interviewer conducted the YMRS, 
CDRS-R, and the K-SADS-PL-W (Kaufman et al., 1997; Geller et al., 1998) with the parent 
and child. Interviewers were trained to administer the YMRS and CDRS-R in an unfiltered 
manner. The YMRS and CDRS-R were administered before the KSADS-PL-W, ensuring 
that the interviewer was blind to diagnosis at time of administration.
Measures
Diagnoses were made with the K-SADS-PL-W, the gold standard for assessing psychiatric 
disorders in children. Many versions have been adapted from the original KSADS; all are 
semi-structured interviews with demonstrated good reliability and validity (Chambers et al, 
1985; Kaufman et al., 1997; Geller et al., 1998; Geller et al., 2001). The K-SADS-PL-W 
ascertained presence of manic and depressive symptoms within the context of a mood 
episode (i.e., filtered rating).
The YMRS and CDRS-R provided unfiltered ratings of symptom severity. The YMRS 
includes 11-items; seven are rated from 0 (Absent) to 4; four from 0 to 8; total scores range 
from 0 to 60. Scores were obtained via separate interviews with both parent and child 
regarding symptoms occurring over the past 2 weeks. Interviewers used clinical judgment to 
resolve discrepancies between parent and youth report. Cronbach’s alpha for the YMRS in 
this sample was .76.
The CDRS-R is a 17-item scale administered to both parent and child in separate interviews 
about symptoms over the past 2 weeks. Parents were asked all items. Children were asked 
14 items and were rated based on observation for 3 items: Depressed Affect, Tempo of 
Speech, and Hypoactivity. Total scores range from 17 (no symptoms) to 113. Three items 
are rated from 1 (No Symptom) to 5; 12 items are rated from 1 to 7. Cronbach’s alpha for 
the CDRS-R in the current sample was .81.
Administration of the YMRS and CDRS-R was explicitly administered before the KSADS-
PL-W in an unfiltered way:
“These unfiltered ratings did not require clinical judgment about the reasons for 
symptoms to be manifest. Because a key aspect of the LAMS study is the 
assessment of symptoms, regardless of etiology, over time, these unfiltered ratings 
were obtained to complement those assessments of affective illness that were 
manifest only during the presence or a mood disorder,”
(Findling et al., 2010 p. 1666).
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Diagnosis of Bipolar Spectrum Disorders
Diagnoses of BP-I, BP-II, and cyclothymic disorder used unmodified DSM-IV criteria. We 
operationalized BP-NOS as: 1) elated mood plus 2 associated symptoms of mania or 
irritable mood plus 3 associated symptoms of mania; 2) change in functioning level; 3) 
symptom duration must be ≥ 4 hours within a 24-hour period; and 4) four episodes of ≥ 4 
hours over 4 days must be present in the participant’s lifetime, following the Course of 
Bipolar Youth (COBY) study criteria for BP-NOS (Axelson et al., 2006).
Data Analytic Strategies
YMRS analyses compared children with BD (n=162) to those without BD (n=545). 
Additional analyses compared BD to specific diagnostic groups to address the two factors 
most likely to influence discriminative validity of unfiltered administration: comorbidity and 
symptom overlap (see Table 1). Diagnostic comparison groups included: 1) children with 
ODD/CD (n=293) who had any comorbidity, (“complicated ODD/CD group”); 2) children 
with autism spectrum disorders (ASD (n=32) who had any comorbidity except ODD/CD; 3) 
children with ADHD (n=157) who did not have comorbid ODD/CD or ASD but could have 
other comorbidities (“uncomplicated ADHD group”); and 4) children with anxiety (ANX) 
(PTSD, acute stress disorder, OCD, panic disorder, separation anxiety disorder, specific 
phobia, social phobia, GAD, and/or anxiety disorder NOS) (n=49) who did not have 
comorbid ODD/CD, ASD, or ADHD, but could have other comorbidities.
CDRS-R analyses used three different stratifications. First, to increase external validity, 
children with DD (n=124) were compared to all others, including those with BD in 
comparison groups (n=583). Second, to address the complication that children with BD 
experience depressive symptoms, children with BD were excluded, creating a “pure’ 
comparison of DD versus non-mood disorders (n=421). Third, to address the clinical reality 
that the CDRS-R is used to assess both BD and DD, a mood group was formed by 
combining BD and DD (n=286). All CDRS-R analyses were conducted comparing those 
with DD, or a mood disorder in the third stratification, to those without DD, or any mood 
disorders in the third stratification. Additional comparisons addressed symptom overlap and 
comorbidity, which are likely to impact the discriminative validity of unfiltered CDRS-R 
administration (see Table 2). Comparison groups consist of : 1) children with ODD/CD and 
any comorbidity; and 2) children with ANX and any comorbidity except ODD/CD (see 
Table 6).
Receiver Operating Characteristic (ROC) analyses examined how well unfiltered YMRS 
and CDRS-R administration predicted presence or absence of BD or DD, respectively, in 
this sample. ROC was originally used as an electrical signal detection procedure in World 
War II to detect signal from noise (Metz, 1986). As the most basic property of a test of 
diagnostic accuracy, discriminative validity should reflect a test’s ability to distinguish 
between two states of health (e.g., disease versus no disease). The most common index of 
accuracy in ROC analysis is area under the curve (AUC), the probability of correctly 
distinguishing two randomly chosen participants. An AUC of .50 means the test does not 
distinguish more than chance, whereas an AUC of 1.0 means the test distinguishes perfectly. 
Common standards for interpreting AUC values are: .60–.70, poor accuracy; .70–.80, 
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moderate accuracy; .80–.90, good accuracy; and .90–1.00, high accuracy (Swets, 1988). 
However, in mental health applications, good tests often provide AUC values of .70 to .80; 
values higher than .90 frequently indicate flawed designs in which the comparison group 
consists of healthy controls or other comparators of minimal clinical relevance (Bossuyt et 
al., 2003; Youngstrom, Meyers, Youngstrom, Calabrese, & Findling, 2006). We tested 
whether the YMRS performed significantly less well when administered in an unfiltered 
manner by testing the difference between the AUC from the present sample versus the 
filtered administration results in separate data published by Youngstrom et al. (2005) and 
Frazier et al. (2007) using Hanley and McNeil’s (1983) z-test of independent AUCs. The 
same method was used for the CDRS-R.
We estimated sensitivity, specificity, positive predictive value (PPV), and negative 
predictive value (NPV) for cut points that maximized the combination of sensitivity and 
specificity, treating costs of false positive and false negatives as equal. We estimated multi-
level diagnostic likelihood ratios (DLRs) based on YMRS and CDRS-R quintiles. DLRs are 
the change in odds of a given outcome (e.g., diagnosis of BD) and can be derived from 
sensitivity and specificity (Straus, Glasziou, Richardson, & Haynes, 2011). DLRs can be 
used to find posterior probability, which is the new probability of a disorder given a certain 
test result. A visual nomogram, analogous to a slide rule, is used to combine previous 
probability (i.e., base rate) with the test result (i.e., the DLR corresponding to the 
appropriate quintile) to find the posterior probability, which is equivalent to PPV. 
Nomograms use nonlinear spacing to accomplish these transformations, which would 
require several computations; it is the same use of geometry that handles multiplication and 
ratios underlying old-fashioned slide rules (Straus, Glasziou, Richardson, & Haynes, 2011). 
DLRs greater than 10 or less than 0.1 are considered clinically decisive because they can 
change a prior probability of 50% to more than 90% or less than 10% posterior probability 
(Youngstrom, Meyers, Youngstrom, Calabrese, & Findling, 2006a).
Results
Preliminary Analyses
Given the small amount of missing data (< 5%), listwise deletion provided an adequate 
solution (Allison, 2002). Table 3 presents demographics for participants with BD and 
comparison groups. Participants with BD were significantly older than all comparison 
groups except ASD and ANX. Although statistically significant, the absolute age differences 
were unremarkable (< 1 year) and Cohen’s d effect sizes were small (largest d = 0.35). The 
BD group contained a significantly lower proportion of males and white participants than all 
comparison groups except for the ASD and ANX groups. The BD group had significantly 
lower CGAS scores, indicating poorer overall functioning, than the complicated ODD/CD, 
uncomplicated ADHD, and ANX groups, but significantly higher CGAS scores than the 
ASD group. All groups (BD, No BD, ODD/CD, ADHD, and ANX) had mean CGAS scores 
within the same moderate impairment range, except for the ASD group, which had an 
average CGAS score in the serious impairment range.
Participants within the DD group and within the mood group (Table 4) were significantly 
older than all comparison groups. Although statistically significant, the difference between 
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average ages did not exceed 1.1 years, and Cohen’s d effect sizes were small to medium 
(largest d = 0.52). The DD and mood groups had significantly lower proportions of white 
participants. The ANX group was comprised of a significantly lower proportion of 
participants on Medicaid than the DD or mood groups. The DD and mood groups had 
significantly lower CGAS scores (i.e., poorer overall functioning) than all comparison 
groups. Of note, all groups had average CGAS scores within the same moderate impairment 
range.
DSM-IV Disorders and Comorbidity
Comorbid disorders at listed in Tables 5–6. The most common comorbid diagnosis was 
ADHD, occurring in 72% of participants with BD, 77% of participants with DD, and 74% of 
participants with either mood disorder. Within the BD group, 42% had ODD/CD, 40% had 
ANX, 31% had some other diagnosis (e.g., enuresis), and 3% had ASD. Within the DD 
group, 71% had ANX, 56% had ODD/CD, 30% had some other diagnosis, and 2% had 
ASD. Within the mood group, 57% had BD, 54% had ANX, 48% had ODD/CD, 43% had 
DD, 30% had some other diagnosis, and 2% had ASD.
Discriminative Validity of the Unfiltered YMRS Administration
ROC analyses evaluated discriminative validity of the YMRS. When participants with BD 
were compared to all others, accuracy of predicting BD was in the good range (AUC = .84, 
95% CI = .80–.87). The optimal cut point was 22.5. Sensitivity for the YMRS when BD was 
compared with all other disorders was .68 and specificity was .86. As hypothesized, 
unfiltered administration was significantly less discriminating than filtered administration 
(AUC = .95, SE = 0.013), z = 7.65, p < .0005 and (AUC = .97, SE = 0.012), z = 5.89,p < .
0005, comparing present results to those for treatment seeking youth aged 5–18 in 
Youngstrom et al. (2005) and aged 4–14 in Frazier et al. (2007), respectively, using the 
Hanley & McNeil (1983) procedure.
Predicting BD also fell within the good range when compared to the complicated ODD/CD 
group (AUC = .80, 95% CI = .76–.84); the ASD group (AUC = .80, 95% CI = .72–.88); and 
the uncomplicated ADHD group (AUC = .88, 95% CI = .84–.92). High accuracy was 
achieved when discriminating BD from ANX (AUC = .90, 95% CI = .86–.95). Table 7 
presents AUCs for all YMRS comparisons, sensitivity, specificity, PPV, and NPV for the 
observed sample base rates.
Controlling for age, gender, race, and CGAS scores had minimal effects on AUC values for 
BD versus No BD, ODD/CD, ADHD, and ANX (AUC values changed 0.01–0.03). AUC 
increased 0.10 for the BD versus ASD comparison when controlling for demographics.
Discriminative Validity of the Unfiltered CDRS-R Administration
ROC analyses also tested discriminative validity of the CDRS-R. Three sets of analyses 
addressed complications of comparing participants with DD to participants with BD, as both 
experience depressive symptoms. First, the DD group was compared to all other 
participants, with BD folded into the comparison group. In these analyses, accuracy of 
predicting DD was moderate (AUC = .78, 95% CI = .74–.82), with an optimal cut point of 
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38.5 and corresponding sensitivity of .73 and specificity of .74. When BD was folded into 
comparison groups, unfiltered administration was not significantly less discriminating than 
filtered administration (AUC = .81, SE = 0.015), z = 1.05, p = .295, comparing present 
results to those for treatment seeking youth aged 5–18 in Youngstrom et al. (2005) using the 
Hanley & McNeil (1983) procedure.
Controlling for age, gender, race, and CGAS scores had minimal effects on AUC values for 
DD versus No DD and ODD/CD (AUC values changed 0.02–0.03). AUC increased 0.07 for 
the DD versus ANX comparison when controlling for demographics.
Second, participants with BD diagnoses were removed from the CDRS-R ROC analysis, 
leaving a “pure” comparison of DD versus all other non-mood diagnoses. Accuracy 
improved and was within the good range (AUC = .84, 95% CI = .80–.88), with an optimal 
cut point of 36.5 and corresponding sensitivity of .76 and specificity of .79. For the pure 
comparison of DD versus all non-mood diagnoses, unfiltered administration was 
significantly less discriminating than filtered administration (AUC = .93, SE = 0.010), z 
=3.94, p < .0005, comparing present results to those of Youngstrom et al. (2005) using the 
Hanley & McNeil (1983) procedure. Controlling for age, gender, race, and CGAS scores 
had minimal effects on AUC values for DD versus No DD and ODD/CD (AUC values 
changed 0.02). AUC increased 0.07 for the DD versus ANX comparison when controlling 
for demographics.
Third, BD and DD were combined into a mood group and compared to all other participants, 
which had moderate accuracy of distinguishing mood disorders (AUC = .77, 95% CI = .74–.
81). Unfiltered administration was significantly less discriminating than filtered 
administration (AUC = .93, SE = 0.009), z =7.65, p < .0005, comparing present results to 
those of Youngstrom et al. (2005), using the Hanley & McNeil (1983) procedure. Table 7 
presents AUCs for all CDRS-R comparisons, sensitivity, specificity, PPV, and NPV for 
sample base rates in the present sample. Controlling for age, gender, race, and CGAS scores 
AUC values increased 0.04–0.07 for mood comparisons.
Change in Odds of a BD or DD Diagnosis: Diagnostic Likelihood Ratios (DLRs)
Multi-level DLRs were calculated for YMRS and CDRS-R quintiles to examine change in 
odds of a BD or DD diagnosis given different test scores. For the YMRS, DLRs were 
calculated for all comparison groups except ASD. DLRs could not be calculated for all 
quintiles of the ASD comparison because some cells had zero participants due to the small 
sample size of the ASD group. Scores in the very high quintile for all remaining 
comparisons (No BD, complicated ODD/CD, uncomplicated ADHD, and ANX) increased 
odds of BD and ranged from 5.74 for BD versus complicated ODD/CD to over 10 for BD 
versus uncomplicated ADHD and BD versus ANX, with the DLR for BD versus all other 
disorders combined falling in between at 6.12 (Table 8). Scores in the very low range for the 
YMRS decreased odds of BD and ranged from 0.09 for BD versus uncomplicated ADHD 
and BD versus ANX to 0.19 for BD versus complicated ODD/CD, with the DLR for BD 
versus all other disorders combined falling in between at 0.10.
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As Figure 1 illustrates, nomograms combine the base rate of BD with DLRs to find the 
probability of BD given a YMRS score within a certain range. For example, the base rate of 
BD in this sample was 23%. The DLR corresponding to a YMRS score in the highest 
quintile was 6.12. Plotted on the nomogram, the odds of a BD diagnosis increases from 23% 
to just over 60%. Therefore, given a YMRS score in the highest range, the probability of BD 
is 60%.
DLRs were calculated for three stratifications of DD (Table 9). Including BD in the 
comparison groups, DLRs associated with the highest CDRS-R quintile were similar and 
ranged from 3.12 to 3.56. Excluding BD from comparison groups, DLRs associated with the 
highest CDRS-R quintile ranged from 5.08 for DD versus No DD to 14.37 for DD versus 
ANX. Combining BD and DD to form a mood group, DLRs associated with the highest 
CDRS-R quintile ranged from 3.92 for Mood versus ANX to 7.56 for Mood versus 
ODD/CD.
Overall, the YMRS and CDRS-R, when administered in an unfiltered manner, have 
moderate to good discriminative validity and are able to increase or decrease the odds of a 
BD or DD diagnosis given scores within the very high or very low scale ranges.
Discussion
It was hypothesized that unfiltered YMRS and CDRS-R administration would result in 
significantly lower discriminative validity due to nosological overlap and comorbid 
presentations than reported in prior work using filtered ratings (e.g., Youngstrom et al., 
2005; Frazier et al., 2007). As hypothesized, the YMRS and the CDRS-R, specifically for 
the pure comparison of DD versus non-mood disorders and the combined BD and DD mood 
group versus non-mood disorders, showed significantly lower AUCs in ROC analyses than 
found using filtered scores. Even so, the YMRS still achieved good discriminative validity 
and the CDRS-R achieved moderate discriminative validity using unfiltered administration 
(Table 7).
Examining sub-comparisons of BD with other diagnostic groups (complicated ODD/CD, 
ASD, uncomplicated ADHD, and ANX), the YMRS was best at discriminating BD from 
uncomplicated ADHD (i.e., no ODD/CD or ASD comorbidities) and BD from ANX. 
Although the difference between AUCs could not be statistically tested due to different 
comparison groups, this trend is consistent with expectations. Uncomplicated ADHD and 
ANX groups lack some of the nosological overlap and much of the qualitative overlap that 
children with complicated ODD/CD have with BD (e.g., temper outbursts, anger, 
aggression, and irritability), consistent with previous literature (e.g., Mick, Spencer, 
Wozniak, & Biederman, 2005).
Looking at CDRS-R sub-comparisons (ODD/CD and ANX), it consistently performed the 
worst when the DD or mood group was compared to ANX. Although the difference between 
AUCs could not be statistically tested due to different comparison groups, this trend is 
consistent with expectations. Depression and anxiety are highly comorbid and have 
substantial nosological overlap (e.g., difficulty concentrating, insomnia, appetite changes). 
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In addition, this makes theoretical and empirical sense given biological/neural findings and 
developmental trajectory studies of internalizing problems (i.e., anxiety in childhood as a 
pathway to depression in adolescence) (Cummings, Caporino, & Kendall, 2013; Lonigan, 
Phillips, & Hooe, 2003; Mineka, Watson, & Clark, 1998).
Sensitivity and specificity, which are independent of base rate, were acceptable for both the 
YMRS and CDRS-R. Positive predictive value (PPV) and negative predictive value (NPV) 
for the YMRS were good. For the CDRS-R, PPV was poor and NPV was good, indicating 
the number of false positives exceeded or was almost equivalent to the number of true 
positives. It is important to note PPV and NPV are affected by base rate. In particular, PPV 
becomes inflated as base rates increases, and NPV tends to be high when the target 
condition is rare. For the total sample, the BD base rate was .23, which may be similar to 
some inpatient settings but is probably higher than outpatient settings and is certainly higher 
than epidemiologic samples (Soutullo et al., 2005; Youngstrom & Duax, 2005; Danner et 
al., 2009; Merikangas & Pato, 2009; Van Meter, Moreira, & Youngstrom, 2011). The total 
sample DD base rate was .18, which may be similar or lower than some outpatient settings 
but higher than epidemiologic estimates (Costello, Erkanli, & Angold, 2006). Therefore, 
PPV and NPV are difficult to generalize to other settings with varying base rates. Evidence 
Based Medicine advocates the probability nomogram, a scale analogous to a slide rule, and 
other implementations of Bayesian methods to address precisely this limitation (Straus, 
Glasziou, Richardson, & Haynes, 2011).
Therefore, DLRs, which are independent of base rates and easy to use in practice with the 
aid of a nomogram, were calculated for YMRS and CDRS-R quintiles. An example, visually 
combining prior probability (i.e., base rate) with DLRs to determine posterior probability 
(i.e., PPV), is plotted on a nomogram in Figure 1. The use of nomograms as evidence-based 
assessment tools has been shown to improve clinicians’ accuracy of diagnosis of pediatric 
BD and decrease variability among clinicians’ diagnoses as well as decrease over-diagnosis 
of BD (Jenkins, Youngstrom, Feeny, Findling, & Youngstrom, 2011; Jenkins, Youngstrom, 
Washburn, & Youngstrom, 2011). Moreover, nomograms were rated by clinicians as easy to 
use, and a majority of clinicians said they would use them in their practice after receiving 
feedback about their improved accuracy (Jenkins, Youngstrom, Feeny, Findling, & 
Youngstrom, 2011).
The change in odds of a BD diagnosis was increased in the very high range of the YMRS for 
all comparisons. Given a YMRS score in the highest quintile when comparing BD to all 
other disorders, the probability of a BD diagnosis increased from the study base rate of 23% 
to just over 60%. Change in odds of a DD or mood diagnosis is slightly increased in the very 
high range of the CDRS-R for all comparisons.
DLRs can be applied across settings with different base rates with the use of a nomogram; 
however, it is important to note that the YMRS and CDRS-R, even with use of a nomogram, 
are not sufficient for making a diagnosis of BD or DD. YMRS and CDRS-R scores and use 
of a nomogram can inform the diagnostic process but cannot replace more thorough 
assessment of DSM-IV (or DSM-5) symptoms, family history, life events, and other 
contextual factors.
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Differences on average YMRS and CDRS-R total scores do not discount the substantial 
nosological overlap among disorders, but speak to the ability of the YMRS and CDRS-R to 
differentiate groups on factors beyond nosological similarity and highlight the possibility 
that there are qualitative differences on overlapping symptoms between mood disorders and 
other disorders. Mick, Spencer, Wozniak, & Biederman (2005) posited irritability in BD is 
qualitatively different and more severe than other forms of irritability. Although not 
examined in detail here, perhaps other items common across disorders are qualitatively 
different. For example, “talks a lot” could be endorsed for either ADHD or mania, but 
chronic talkativeness versus episodic periods of pressured speech might be qualitatively 
different in ways that more nuanced assessments could distinguish.
Overall, the YMRS and CDRS-R, when administered in an unfiltered manner, have 
moderate to good discriminative validity and are able to increase or decrease the odds of a 
BD or DD diagnosis given scores within the very high or very low ranges of the scales. 
Nosological overlap among disorders did not eliminate the discriminative validity of the 
YMRS or CDRS-R. These findings are particularly encouraging considering the importance 
of accurate and effective outcome measures and the widespread use of the YMRS and 
CDRS-R in clinical research on pediatric BD.
All participants were treatment-seeking families at outpatient clinics associated with four 
universities conducting the LAMS study, and participants were screened with the intent of 
increasing the odds of BD in this sample. Therefore, the current study’s sample is enriched 
for BD, which could inflate diagnostic performance statistics, although statistics 
theoretically independent of base rate (e.g., DLRs) should remain generalizable (Zhou et al., 
2002).
Raters were specifically instructed and trained to rate the YMRS and CDRS-R in an 
unfiltered manner. However, the same rater administered the YMRS, CDRS-R, and 
KSADS-PL-W. Raters administered the YMRS and CDRS-R before the KSADS-PL-W, and 
therefore were blind to diagnosis during their administration but not by the end of the 
interview. Future prospective studies should examine discriminative validity of unfiltered 
YMRS and CDRS-R administration with raters completely blind to diagnoses (Bossuyt et 
al., 2003). In addition, replication of this study in an adolescent population would allow for 
comparison of scores between the adolescent manifestation of mood, anxiety, behavior, and 
autism symptoms as well as other conditions more common to this developmental phase 
(e.g., substance abuse).
The ability of the YMRS and CDRS-R to differentiate BD and DD from other disorders 
does not negate the substantial nosological overlap between mood disorders and other 
disorders. Therefore, more work is needed to understand and flesh out the differences and 
similarities among diagnostic groups on the YMRS and CDRS-R, potentially with item 
analysis of unfiltered YMRS and CDRS-R administrations.
It is important to note that these results do not support the use of unfiltered administration of 
the YMRS and CDRS-R as diagnostic tools. These measures were not intended to be 
diagnostic tools and do not cover all diagnostic criteria, including all DSM-IV symptoms, 
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duration, and alternative explanations or causes for symptoms. Diagnoses remain guided by 
DSM-IV (or DSM-5) and should be informed by additional information not captured in the 
YMRS and CDRS-R, such as family history, medical history, traumatic life events, as well 
as onset and course of symptoms (e.g, Youngstrom, Findling, Youngstrom, & Calabrese, 
2005; AACAP, 2007; Fields & Fristad, 2009; Youngstrom, Freeman, & Jenkins, 2009).
Filtered YMRS and CDRS-R administration (Youngstrom et al., 2005; Fraizer et al., 2007) 
achieved better discriminative validity than the current results for unfiltered administration. 
Therefore, filtered administration of these measures is still recommended for highest quality 
performance. However, current data support the use of unfiltered administration of the 
YMRS and CDRS-R in situations when it is unfeasible, due to lack or time or training, to 
conduct a KSADS or other diagnostic interview before assessing mood symptoms. The use 
of unfiltered YMRS and CDRS-R administration may also be particularly useful in clinical 
or research settings where symptom presentation is of foremost interest.
These instruments provide a useful means to monitor symptom severity over time and to 
measure treatment response. In addition, when used in a new evaluation, as described above, 
low scores indicate that more extensive evaluation of mood symptoms is not likely needed 
whereas high scores would direct the clinician to more thoroughly determine presence/
absence of depressive or bipolar spectrum disorders. This is similar to good clinical practice 
using screening instruments for anxiety, disruptive behavior or autism – low scores decrease 
the need for further exploration of the disorder in question whereas high scores invite further 
investigation (Youngstrom, Choukas-Bradley, Calhoun, & Jensen-Doss, 2014).
Although results need to be replicated, initial results provide support for good discriminative 
validity of unfiltered administration of the YMRS and CDRS-R, which is encouraging given 
their use in the rapidly growing area of research on pediatric BD.
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Probability nomogram marked up to estimate probability of bipolar diagnosis
An example of how to use a nomogram for the YMRS in the current sample. The first 
column is the study base-rate for BD, the second column is the calculated DLR for quintiles 
of the YMRS, and the third column is PPV, which can be interpreted as the probability of 
having BD if a test result falls within the corresponding quintile. DLRs corresponding to the 
highest and lowest YMRS quintiles are plotted for the BD vs. No BD comparison. The first 
column base-rate changes for different settings and local base-rates should be used.
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